It is recently indicated tumor-initiating cells (T-IC), a small subset in cancer that has the capacities of self-renewal, mutipotent differentiation and tumorigenicity, may be affected by AR activation in prostate cancer, contributing to the progression of the malignant tumors [4–7]. This evidence concerns the gene AR and cancer.